MKMerck KGaASee all their emails
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
A real announcement email from Merck KGaA. Captured July 8, 2026.
Make this email yours
Migma AI designs one like it with your logo, colors, and images.
About this email
Captured Announcement
Merck announces FDA Breakthrough Therapy designation for enpatoran in lupus patients with active skin manifestations.
Top-aligned logo in purple header, followed by a blue hero section with title and image. The body is a single-column text layout with bullet points, followed by a downloads section and corporate footer.
Color palette
Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.